ArticleCancers2021

Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study.

Florian Seydel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.